MUMSS
WST icon

Mitsubishi UFJ Morgan Stanley Securities’s West Pharmaceutical WST Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10
Closed -$2K – 190
2022
Q4 		$2K Sell
10
-10
-50% -$2.37K 0.02% 187
2022
Q3 		$5K Hold
20
– – 0.07% 147
2022
Q2 		$6K Hold
20
– – 0.01% 140
2022
Q1 		$8K Sell
20
-60
-75% -$23.5K 0.01% 131
2021
Q4 		$38K Sell
80
-90
-53% -$38.7K 0.02% 100
2021
Q3 		$72K Buy
+170
New +$71.7K 0.07% 48

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's WST Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 10 shares — an estimated $2K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in WST in Q3 2021 and held it in 6 quarters. The position peaked at $72K in Q3 2021. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 10 West Pharmaceutical shares in Q1 2023, an estimated $2K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in West Pharmaceutical in Q3 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's West Pharmaceutical position peaked at $72K in Q3 2021.
  • 695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.